| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 2.62e-05 | 23 | 153 | 4 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 3.13e-05 | 24 | 153 | 4 | GO:0019957 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 4.34e-05 | 26 | 153 | 4 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 4.34e-05 | 26 | 153 | 4 | GO:0004950 | |
| GeneOntologyMolecularFunction | chemokine (C-C motif) ligand 7 binding | 5.83e-05 | 2 | 153 | 2 | GO:0035717 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.02e-04 | 97 | 153 | 6 | GO:0004896 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.14e-04 | 33 | 153 | 4 | GO:0019956 | |
| GeneOntologyMolecularFunction | chemokine (C-C motif) ligand 5 binding | 1.74e-04 | 3 | 153 | 2 | GO:0071791 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.11e-04 | 157 | 153 | 7 | GO:0019955 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | ABCC4 NCF1 HTATIP2 PTGR2 GPD1L ALDH1A2 FDXR AIFM3 CYP4X1 HSD17B12 HADHA KDM1B NQO2 BBOX1 PLOD2 NCF1B | 2.70e-04 | 766 | 153 | 16 | GO:0016491 |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 3.46e-04 | 4 | 153 | 2 | GO:0015311 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO2 ABCC4 AQP12A TRPC3 SLC17A4 HCN2 SLC30A4 SLC18B1 AQP12B ITPR3 P2RX4 SLC18A3 SCN5A SEC61A1 GABRA6 | 7.36e-04 | 758 | 153 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | channel activity | ANO2 AQP12A TPTE2 TRPC3 HCN2 AQP12B ITPR3 PIEZO2 P2RX4 SCN5A SEC61A1 GABRA6 | 7.42e-04 | 525 | 153 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO2 AQP12A TPTE2 TRPC3 HCN2 AQP12B ITPR3 PIEZO2 P2RX4 SCN5A SEC61A1 GABRA6 | 7.54e-04 | 526 | 153 | 12 | GO:0022803 |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 5.54e-05 | 29 | 152 | 4 | GO:0030867 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYH10 OGT MYOT EPHA6 PDPK1 NCF1 HCN2 TENM2 PTK2 ITPR3 CCR2 P2RX4 PABPC3 KNCN XRN1 ROBO1 SYT5 CCR1 PLCB4 NCF1B ABHD12 GABRA6 | 8.08e-05 | 1228 | 152 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 OGT MYOT PDPK1 NCF1 HCN2 ITPR3 CCR2 P2RX4 KNCN XRN1 ROBO1 SYT5 CCR1 NCF1B GABRA6 | 3.92e-04 | 835 | 152 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | MYH10 OGT MYOT PDPK1 NCF1 HCN2 ITPR3 CCR2 P2RX4 CCT5 KNCN XRN1 ROBO1 SYT5 CCR1 NCF1B GABRA6 | 4.36e-04 | 929 | 152 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | Sec61 translocon complex | 5.18e-04 | 5 | 152 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | dendrite | MYH10 EPHA6 NCF1 HCN2 TENM2 PTK2 ITPR3 CCR2 P2RX4 PABPC3 XRN1 ROBO1 PLCB4 NCF1B ABHD12 GABRA6 | 5.27e-04 | 858 | 152 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYH10 EPHA6 NCF1 HCN2 TENM2 PTK2 ITPR3 CCR2 P2RX4 PABPC3 XRN1 ROBO1 PLCB4 NCF1B ABHD12 GABRA6 | 5.41e-04 | 860 | 152 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | cell-cell contact zone | 6.21e-04 | 94 | 152 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | translocon complex | 7.73e-04 | 6 | 152 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 1.22e-03 | 64 | 152 | 4 | GO:0005791 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.25e-03 | 223 | 152 | 7 | GO:0098862 | |
| Domain | SecY_su_dom | 6.32e-05 | 2 | 149 | 2 | IPR023201 | |
| Domain | SECY_1 | 6.32e-05 | 2 | 149 | 2 | PS00755 | |
| Domain | SECY_2 | 6.32e-05 | 2 | 149 | 2 | PS00756 | |
| Domain | - | 6.32e-05 | 2 | 149 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 6.32e-05 | 2 | 149 | 2 | IPR019561 | |
| Domain | SecY_CS | 6.32e-05 | 2 | 149 | 2 | IPR030659 | |
| Domain | Aquaporin_12 | 6.32e-05 | 2 | 149 | 2 | IPR023265 | |
| Domain | Plug_translocon | 6.32e-05 | 2 | 149 | 2 | PF10559 | |
| Domain | SecY | 6.32e-05 | 2 | 149 | 2 | PF00344 | |
| Domain | SecY/SEC61-alpha | 6.32e-05 | 2 | 149 | 2 | IPR002208 | |
| Domain | WWE | 1.04e-04 | 12 | 149 | 3 | PF02825 | |
| Domain | WWE-dom | 1.04e-04 | 12 | 149 | 3 | IPR004170 | |
| Domain | WWE | 1.04e-04 | 12 | 149 | 3 | PS50918 | |
| Domain | Aquaporin_11/12 | 1.89e-04 | 3 | 149 | 2 | IPR016697 | |
| Domain | Chemokine_rcpt | 2.58e-04 | 16 | 149 | 3 | IPR000355 | |
| Domain | Sec63 | 3.75e-04 | 4 | 149 | 2 | PF02889 | |
| Domain | Sec63 | 3.75e-04 | 4 | 149 | 2 | SM00973 | |
| Domain | Sec63-dom | 3.75e-04 | 4 | 149 | 2 | IPR004179 | |
| Domain | Myosin_S1_N | 6.22e-04 | 5 | 149 | 2 | IPR008989 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 2.56e-06 | 184 | 115 | 10 | MM15943 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 8.07e-06 | 165 | 115 | 9 | M39400 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 2.30e-05 | 188 | 115 | 9 | M4844 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 2.79e-05 | 44 | 115 | 5 | M13720 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.32e-05 | 11 | 115 | 3 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.43e-04 | 13 | 115 | 3 | M47656 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.43e-04 | 13 | 115 | 3 | MM14553 | |
| Pubmed | MYH10 NCF1 NAP1L1 SMPD4 HUWE1 NCLN ARPC4 ITPR3 EEF1G SF3B3 UBN1 METTL9 CCT5 ALG5 TJP2 HSD17B12 PDCD11 NOC4L HADHA REEP5 SEC61A1 PLOD2 SNRNP200 CUX1 PARP12 | 5.88e-09 | 1440 | 155 | 25 | 30833792 | |
| Pubmed | MYH10 MYH11 ATR NBN TRIP12 SF3B3 MYO1F XRN1 POLR1B SNRNP200 RPL7 PARP12 | 4.67e-08 | 340 | 155 | 12 | 24332808 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A MYH10 OGT NAP1L1 SMPD4 HUWE1 NCLN TRIP12 ARPC4 EEF1G SF3B3 CCT5 ALG5 TJP2 HSD17B12 PDCD11 NOC4L POLR1B HADHA SEC61A1 SNRNP200 RPL7 | 1.05e-07 | 1318 | 155 | 22 | 30463901 |
| Pubmed | Impaired lung dendritic cell activation in CCR2 knockout mice. | 3.46e-07 | 4 | 155 | 3 | 15466386 | |
| Pubmed | Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. | 8.63e-07 | 5 | 155 | 3 | 30323343 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 32117251 | ||
| Pubmed | Genotypes and haplotypes of CCR2 and CCR3 genes in Japanese cedar pollinosis. | 8.63e-07 | 5 | 155 | 3 | 17135764 | |
| Pubmed | SETD1A OGT NAP1L1 NBN HUWE1 EPS15L1 CCT5 XRN1 TJP2 PDCD11 SNRNP200 ELP4 CUX1 | 1.22e-06 | 549 | 155 | 13 | 38280479 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 18070887 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TPST1 ABCC4 MIA3 GINM1 ATR HTATIP2 ISOC1 NCLN METTL9 CDIPT TXNDC16 ROBO1 UBIAD1 REEP5 SEC61A1 PLOD2 ABHD12 FRMD5 PROS1 | 1.85e-06 | 1201 | 155 | 19 | 35696571 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A MYH10 NAP1L1 ISOC1 HUWE1 TRIP12 ARPC4 PTK2 EEF1G SF3B3 UBN1 CCT5 ARVCF XRN1 PDCD11 POLR1B HADHA SNRNP200 RPL7 PARP12 | 2.72e-06 | 1353 | 155 | 20 | 29467282 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EP400P1 ABCC4 MYH10 MIA3 OGT TTLL3 EPHA6 NRF1 AFF3 ASH1L ATP9B ADGRV1 HUWE1 SLC30A4 PTK2 EPS15L1 PLCB4 REEP5 NQO2 MCTP2 CUX1 | 3.12e-06 | 1489 | 155 | 21 | 28611215 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.74e-06 | 202 | 155 | 8 | 33005030 | |
| Pubmed | 3.74e-06 | 202 | 155 | 8 | 24639526 | ||
| Pubmed | The multiple personalities of the chemokine receptor CCR7 in dendritic cells. | 4.78e-06 | 8 | 155 | 3 | 16621978 | |
| Pubmed | Determination of the sites of tyrosine O-sulfation in peptides and proteins. | 4.78e-06 | 8 | 155 | 3 | 17558413 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | MYH10 NAP1L1 HUWE1 EEF1G SF3B3 CCT5 HSD17B12 SEC61A1 SNRNP200 | 5.19e-06 | 281 | 155 | 9 | 30455355 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 MIA3 INTS7 NAP1L1 HUWE1 NCLN TRIP12 ITPR3 CDIPT ALG5 HSD17B12 HADHA UBIAD1 SEC61A1 PLOD2 ABHD12 | 5.27e-06 | 942 | 155 | 16 | 31073040 |
| Pubmed | 5.81e-06 | 285 | 155 | 9 | 32838362 | ||
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 6.15e-06 | 287 | 155 | 9 | 36180891 | |
| Pubmed | MYH10 MYH11 OGT NAP1L1 ARPC4 GPD1L EPS15L1 EEF1G SF3B3 CCT5 ARVCF PABPC3 CDIPT XRN1 TJP2 HADHA REEP5 ABHD12 SNRNP200 RPL7 | 6.26e-06 | 1431 | 155 | 20 | 37142655 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 6.81e-06 | 156 | 155 | 7 | 30409884 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 22729248 | ||
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 12070001 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 7.23e-06 | 221 | 155 | 8 | 29991511 | |
| Pubmed | MYH10 NAP1L1 HUWE1 TRIP12 ITPR3 CCT5 XRN1 TJP2 PDCD11 NOC4L HADHA SNRNP200 RPL7 | 8.00e-06 | 653 | 155 | 13 | 22586326 | |
| Pubmed | MIA3 WIPI1 NAP1L1 SMPD4 ITPR3 EPS15L1 XRN1 ROBO1 UBIAD1 REEP5 ELP4 CUX1 | 1.00e-05 | 568 | 155 | 12 | 37774976 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 ATR HUWE1 EEF1G SF3B3 CCT5 SCN5A HADHA SNRNP200 RPL7 CUX1 | 1.06e-05 | 477 | 155 | 11 | 31300519 |
| Pubmed | MYH10 MIA3 ISOC1 HUWE1 NCLN TENM2 EPS15L1 EEF1G CCT5 XRN1 TJP2 SMPD2 HADHA TMEM35A REEP5 ABHD12 ELP4 | 1.42e-05 | 1139 | 155 | 17 | 36417873 | |
| Pubmed | 1.48e-05 | 244 | 155 | 8 | 28902428 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 MYH11 MIA3 ASH1L ISOC1 HUWE1 ARPC4 EEF1G SF3B3 CCT5 RBM46 HADHA SNRNP200 RPL7 | 1.66e-05 | 807 | 155 | 14 | 30575818 |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 1.79e-05 | 121 | 155 | 6 | 31900314 | |
| Pubmed | Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. | 1.85e-05 | 12 | 155 | 3 | 21057511 | |
| Pubmed | Reduced expression of SRC family kinases decreases PI3K activity in NBS1-/- lymphoblasts. | 1.97e-05 | 2 | 155 | 2 | 18835245 | |
| Pubmed | Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations. | 1.97e-05 | 2 | 155 | 2 | 25120743 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 35979635 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9438424 | ||
| Pubmed | Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. | 1.97e-05 | 2 | 155 | 2 | 17116734 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 35013585 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 1.97e-05 | 2 | 155 | 2 | 10906735 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26040420 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25928629 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 36167651 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 7916668 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 18480044 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 16316347 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19745168 | ||
| Pubmed | Identification of a mammalian vesicular polyamine transporter. | 1.97e-05 | 2 | 155 | 2 | 25355561 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17967977 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 18363963 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 7691885 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28954264 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 1.97e-05 | 2 | 155 | 2 | 15809071 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 10733346 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 21703401 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 35785620 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 7683036 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19726746 | ||
| Pubmed | NBS1 directly activates ATR independently of MRE11 and TOPBP1. | 1.97e-05 | 2 | 155 | 2 | 23368512 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19666841 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28892735 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22871590 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28923937 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15616588 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ABCC4 GINM1 ATP9B ARPC4 EPS15L1 ACSM3 ALG5 FDXR ROBO1 SMPD2 PLCB4 UBIAD1 UROD | 2.20e-05 | 719 | 155 | 13 | 35337019 |
| Pubmed | 2.40e-05 | 13 | 155 | 3 | 26572063 | ||
| Pubmed | 2.40e-05 | 13 | 155 | 3 | 24619213 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 NAP1L1 ARPC4 ITPR3 EEF1G SF3B3 CCT5 PDCD11 POLR1B HADHA SEC61A1 MCTP2 SNRNP200 RPL7 | 2.43e-05 | 949 | 155 | 15 | 36574265 |
| Pubmed | 2.53e-05 | 191 | 155 | 7 | 33762435 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | NCLN SLC30A4 ARPC4 SF3B3 METTL9 PABPC3 CDIPT ALG5 FDXR HSD17B12 C1R HADHA REEP5 NQO2 SEC61A1 PLOD2 SNRNP200 RPL7 PARP12 | 2.67e-05 | 1451 | 155 | 19 | 30550785 |
| Pubmed | 3.33e-05 | 135 | 155 | 6 | 31405213 | ||
| Pubmed | 3.80e-05 | 15 | 155 | 3 | 9139699 | ||
| Pubmed | Caspase-11 protects against bacteria that escape the vacuole. | 3.80e-05 | 15 | 155 | 3 | 23348507 | |
| Pubmed | MYH10 OGT HUWE1 TRIP12 ITPR3 SEC61A2 EEF1G SF3B3 CCT5 ARVCF PIK3CA XRN1 HADHA SEC61A1 RPL7 CUX1 PARP12 | 4.44e-05 | 1247 | 155 | 17 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | OGT NAP1L1 SMPD4 HUWE1 NCLN SEC61A2 EEF1G SF3B3 CCT5 PABPC3 CDIPT HSD17B12 POLR1B HADHA SEC61A1 SNRNP200 RPL7 | 4.90e-05 | 1257 | 155 | 17 | 37317656 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | OGT NAP1L1 SF3B3 CCT5 PABPC3 PDCD11 NOC4L POLR1B HADHA SEC61A1 SNRNP200 RPL7 | 5.63e-05 | 678 | 155 | 12 | 30209976 |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 5.90e-05 | 3 | 155 | 2 | 27044504 | |
| Pubmed | KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice. | 5.90e-05 | 3 | 155 | 2 | 22160378 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 5.90e-05 | 3 | 155 | 2 | 18787174 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 24873968 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 22184329 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 23846739 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 5.90e-05 | 3 | 155 | 2 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 5.90e-05 | 3 | 155 | 2 | 20142487 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 27650511 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 29490266 | ||
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 5.90e-05 | 3 | 155 | 2 | 25565313 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 39357591 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 11435342 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 31118934 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 16041040 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 5.90e-05 | 3 | 155 | 2 | 18703411 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 5.90e-05 | 3 | 155 | 2 | 27829407 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 22376231 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 5.90e-05 | 3 | 155 | 2 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 5.90e-05 | 3 | 155 | 2 | 12364355 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 34557202 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 28467721 | ||
| GeneFamily | CD molecules|C-C motif chemokine receptors | 1.80e-05 | 10 | 98 | 3 | 1091 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP | 3.15e-06 | 200 | 155 | 9 | M8532 | |
| Coexpression | ROSS_AML_OF_FAB_M7_TYPE | 3.72e-06 | 70 | 155 | 6 | M4621 | |
| Coexpression | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS | 6.84e-06 | 45 | 155 | 5 | M1985 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | IL10RA GPR155 OGT ATR PLEKHF1 ASH1L TBC1D2B NAP1L1 PHTF2 HUWE1 TRIP12 ADCY7 CCR2 EEF1G TRANK1 SF3B3 METTL9 MYO1F XRN1 CCR6 KIT SNRNP200 RPL7 | 2.35e-05 | 1492 | 155 | 23 | M40023 |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 2.54e-05 | 199 | 155 | 8 | M9173 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 2.64e-05 | 200 | 155 | 8 | M3020 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | IL10RA OGT PLEKHF1 TBC1D2B NAP1L1 PHTF2 TRIP12 ARPC4 ADCY7 EEF1G METTL9 RNASET2 MYO1F CCR6 KIT SNRNP200 RPL7 | 2.96e-05 | 911 | 155 | 17 | M40038 |
| Coexpression | RODWELL_AGING_KIDNEY_UP | IL10RA NCF1 HTATIP2 TBC1D2B ITPR3 ARVCF FDXR SCN5A MYO1F C1R CCR1 PARP12 | 4.58e-05 | 501 | 155 | 12 | M5389 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP | 5.03e-05 | 161 | 155 | 7 | M9446 | |
| Coexpression | HUANG_DASATINIB_RESISTANCE_DN | 6.02e-05 | 70 | 155 | 5 | M16369 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_MYELOID_CELLS | 8.73e-05 | 237 | 155 | 8 | M40264 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | ABCC4 WIPI1 HTATIP2 PHTF2 PTK2 ACSM3 FAM210B XRN1 TXNDC16 MCTP2 | 1.01e-04 | 384 | 155 | 10 | M45735 |
| Coexpression | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP | 1.21e-04 | 81 | 155 | 5 | M17082 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | TTLL3 NAP1L1 NBN GPD1L ALDH1A2 ACSM3 RNASET2 XRN1 PLOD2 PROS1 | 1.36e-04 | 398 | 155 | 10 | M14877 |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.67e-04 | 195 | 155 | 7 | M7926 | |
| Coexpression | GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP | 1.77e-04 | 197 | 155 | 7 | M9730 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN | 1.77e-04 | 197 | 155 | 7 | M3105 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | GPR155 TPST1 MYH11 TTLL3 NAP1L1 GPD1L ROBO1 C1R TMEM35A KIT PCDH9 | 1.77e-04 | 493 | 155 | 11 | M19391 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | ABCC4 MYH10 NCF1 HTATIP2 ARPC4 PTK2 NDC80 CCT5 TJP2 ROBO1 HADHA PLOD2 PROS1 | 1.80e-04 | 669 | 155 | 13 | M18635 |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.83e-04 | 198 | 155 | 7 | M9386 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP | 1.83e-04 | 198 | 155 | 7 | M8335 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP | 1.83e-04 | 198 | 155 | 7 | M9924 | |
| Coexpression | GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN | 1.83e-04 | 198 | 155 | 7 | M5507 | |
| Coexpression | SCIBETTA_KDM5B_TARGETS_UP | 1.83e-04 | 19 | 155 | 3 | M1142 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 1.89e-04 | 199 | 155 | 7 | M5692 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.95e-04 | 200 | 155 | 7 | M5831 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN | 1.95e-04 | 200 | 155 | 7 | M9957 | |
| Coexpression | GSE17721_LPS_VS_CPG_2H_BMDC_DN | 1.95e-04 | 200 | 155 | 7 | M3991 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP | 1.95e-04 | 200 | 155 | 7 | M3920 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | 1.95e-04 | 200 | 155 | 7 | M6185 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN | 1.95e-04 | 200 | 155 | 7 | M3895 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP | 1.95e-04 | 200 | 155 | 7 | M6936 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP | 1.95e-04 | 200 | 155 | 7 | M4327 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SETD1A MIA3 OGT NCLN ITPR3 SEC61A2 SF3B3 CDIPT HSD17B12 PDCD11 UBIAD1 SEC61A1 ABHD12 | 2.14e-04 | 681 | 155 | 13 | M5314 |
| Coexpression | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD | 2.49e-04 | 21 | 155 | 3 | M1986 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-07 | 192 | 155 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 196 | 155 | 8 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-07 | 197 | 155 | 8 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 2.01e-06 | 167 | 155 | 7 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 168 | 155 | 7 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-06 | 173 | 155 | 7 | 0a0127bcb1d7b2b6125faef576dd843055095528 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 176 | 155 | 7 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-06 | 186 | 155 | 7 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-06 | 189 | 155 | 7 | c38157c8cf5c0c1f560011ef5cc5892a049ee2b7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-06 | 190 | 155 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 193 | 155 | 7 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 194 | 155 | 7 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 194 | 155 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-06 | 194 | 155 | 7 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.77e-06 | 196 | 155 | 7 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.77e-06 | 196 | 155 | 7 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-06 | 196 | 155 | 7 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-06 | 196 | 155 | 7 | a692cee9254f3771a076b290688a4d0120c02c3b | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-06 | 197 | 155 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | Severe-CD8+_T_activated|Severe / Disease group and Cell class | 5.97e-06 | 197 | 155 | 7 | bb1e3e1d841c2c7141eb1099e7755860b168b6fc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 197 | 155 | 7 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-06 | 197 | 155 | 7 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 197 | 155 | 7 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 198 | 155 | 7 | 4ba72ba1f0cebc93053aae72d763c33e155b6fa4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 199 | 155 | 7 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.37e-06 | 199 | 155 | 7 | ba144739f65560207303c0143e8de1e86922bebb | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.37e-06 | 199 | 155 | 7 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 6.37e-06 | 199 | 155 | 7 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 199 | 155 | 7 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.37e-06 | 199 | 155 | 7 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 144 | 155 | 6 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.87e-05 | 157 | 155 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 160 | 155 | 6 | 984990be02642a562f0c60ea99c01f005e7c02c2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.31e-05 | 163 | 155 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | baf6c40b004433c6b1d0bbbb74f73fcd6ee162ea | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | 8d089844896e84935eab705ebe54f125c4b6d9ca | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | 17fb1421476ba44999b1165f2576514f74c1f882 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | 1fc64b21e97e651f88a92de51536b3753f3e08d6 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 166 | 155 | 6 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 166 | 155 | 6 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 167 | 155 | 6 | 7f9eedf68a800159c5642e04dd9569ae58109bd5 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 168 | 155 | 6 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 168 | 155 | 6 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 171 | 155 | 6 | 33869b9fab2c94cb33f1cc659073fcf2bb30c22d | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 171 | 155 | 6 | 4ad28ecfde3d529a09b80be908c446bd5274518e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 35d09640d5b04fa0bbb1b40d4b8f97da587a5046 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 98cb64e2a768908105701a7a5b58f336036250fd | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 0457ccc18697aaec44b7c30ae157aae8f48d8785 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 172 | 155 | 6 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | FLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster | 3.22e-05 | 173 | 155 | 6 | 32b8e5b400885dbeba57a7cb2c18d882664dc285 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 3.22e-05 | 173 | 155 | 6 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-05 | 173 | 155 | 6 | e3cb7c8c09f937da6b8d673e9adfec5d94a15548 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 173 | 155 | 6 | 50b25b7f8f29b60c22782a4492fe4b089fe7d69d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-05 | 173 | 155 | 6 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-05 | 174 | 155 | 6 | 7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-05 | 176 | 155 | 6 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.66e-05 | 177 | 155 | 6 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.66e-05 | 177 | 155 | 6 | 1e7b4c0e41649d57a2c219a3b7e693538b8b34e4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 178 | 155 | 6 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-05 | 179 | 155 | 6 | 409364d916c5e7e2291284cc74351d8f8a8447ac | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 4.15e-05 | 181 | 155 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 4.15e-05 | 181 | 155 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 181 | 155 | 6 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 4.15e-05 | 181 | 155 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 181 | 155 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 181 | 155 | 6 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | facs-Marrow|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 185 | 155 | 6 | e40f0a0439834c3025d6c7832977be4e37a94c44 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-05 | 185 | 155 | 6 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.69e-05 | 185 | 155 | 6 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-05 | 186 | 155 | 6 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-05 | 186 | 155 | 6 | c0a58e43a813441d3a1708236737b15db8bea10e | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 4.97e-05 | 187 | 155 | 6 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 187 | 155 | 6 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-05 | 188 | 155 | 6 | c7c2cf1aa328e735073d6031e44b5dbd55beae6d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-05 | 188 | 155 | 6 | 977ebc0f88cb3ea3c422c85d84b3546229af5d3f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 188 | 155 | 6 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 189 | 155 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 189 | 155 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 5.43e-05 | 190 | 155 | 6 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.43e-05 | 190 | 155 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.43e-05 | 190 | 155 | 6 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 191 | 155 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 191 | 155 | 6 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-05 | 191 | 155 | 6 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 191 | 155 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 5.76e-05 | 192 | 155 | 6 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 192 | 155 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 192 | 155 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 5.76e-05 | 192 | 155 | 6 | e54577183b09599a3b2bdd532a18ea8f4a6e3524 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.76e-05 | 192 | 155 | 6 | 6d7dd35869d86c3e991a61e17825053a3bfab44d | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-05 | 192 | 155 | 6 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-05 | 193 | 155 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 193 | 155 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 193 | 155 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | wk_08-11-Hematologic-Myeloid-CX3CR1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.93e-05 | 193 | 155 | 6 | afc20433b5abc9b430751a2aa8d93b0fd136a888 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.93e-05 | 193 | 155 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 193 | 155 | 6 | db26b79dfe9c48388f6b64dceb21073d104ab504 | |
| Disease | fungal infectious disease (is_marker_for) | 1.57e-04 | 4 | 152 | 2 | DOID:1564 (is_marker_for) | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 2.61e-04 | 5 | 152 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | Acute myelomonocytic leukemia | 2.61e-04 | 5 | 152 | 2 | C0023479 | |
| Disease | disease of metabolism (is_implicated_in) | 3.90e-04 | 6 | 152 | 2 | DOID:0014667 (is_implicated_in) | |
| Disease | Brugada syndrome | 7.23e-04 | 8 | 152 | 2 | cv:C1142166 | |
| Disease | Graves disease | 8.28e-04 | 81 | 152 | 4 | EFO_0004237 | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 9.27e-04 | 9 | 152 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | Parkinson disease, disease progression measurement | 1.07e-03 | 39 | 152 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | Cutaneous Melanoma | 1.24e-03 | 41 | 152 | 3 | C0151779 | |
| Disease | polymyositis (is_marker_for) | 1.41e-03 | 11 | 152 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | argininosuccinate measurement | 1.41e-03 | 11 | 152 | 2 | EFO_0010461 | |
| Disease | multisite chronic pain | 1.50e-03 | 95 | 152 | 4 | EFO_0010100 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.68e-03 | 12 | 152 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.68e-03 | 12 | 152 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Brugada Syndrome 1 | 1.98e-03 | 13 | 152 | 2 | C4551804 | |
| Disease | Leukemia, Myelocytic, Acute | 2.07e-03 | 173 | 152 | 5 | C0023467 | |
| Disease | glycerophospholipid measurement | 2.08e-03 | 49 | 152 | 3 | EFO_0007630 | |
| Disease | Rheumatoid Arthritis | 2.12e-03 | 174 | 152 | 5 | C0003873 | |
| Disease | Yu-Zhi constitution type | 2.65e-03 | 15 | 152 | 2 | EFO_0007638 | |
| Disease | cancer (implicated_via_orthology) | 2.73e-03 | 268 | 152 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Pneumonia | 2.74e-03 | 54 | 152 | 3 | C0032285 | |
| Disease | Lobar Pneumonia | 2.74e-03 | 54 | 152 | 3 | C0032300 | |
| Disease | Pneumonitis | 2.74e-03 | 54 | 152 | 3 | C3714636 | |
| Disease | Experimental Lung Inflammation | 2.74e-03 | 54 | 152 | 3 | C0887898 | |
| Disease | neuroblastoma | 3.10e-03 | 116 | 152 | 4 | EFO_0000621 | |
| Disease | Benign neoplasm of stomach | 3.41e-03 | 17 | 152 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.41e-03 | 17 | 152 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.41e-03 | 17 | 152 | 2 | C0154060 | |
| Disease | dermatomyositis (is_marker_for) | 3.41e-03 | 17 | 152 | 2 | DOID:10223 (is_marker_for) | |
| Disease | Malignant neoplasm of endometrium | 3.82e-03 | 18 | 152 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.82e-03 | 18 | 152 | 2 | C0346191 | |
| Disease | Ulcerative Colitis | 4.25e-03 | 63 | 152 | 3 | C0009324 | |
| Disease | Allergic Reaction | 4.25e-03 | 63 | 152 | 3 | C1527304 | |
| Disease | Chronic myeloproliferative disorder | 4.26e-03 | 19 | 152 | 2 | C1292778 | |
| Disease | Malignant Neoplasms | 4.41e-03 | 128 | 152 | 4 | C0006826 | |
| Disease | rheumatoid arthritis, COVID-19 | 4.44e-03 | 64 | 152 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | Hypersensitivity | 4.44e-03 | 64 | 152 | 3 | C0020517 | |
| Disease | COVID-19, osteoarthritis | 4.71e-03 | 20 | 152 | 2 | MONDO_0005178, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRRVYKGEFQLPDFL | 346 | O60507 | |
| KELEEQFYTLVPFGR | 736 | P51826 | |
| GFLDKQGFYVALRLV | 66 | Q9UBC2 | |
| PIHVVFFVSGKYLRQ | 2031 | Q9NR48 | |
| KALLPVGAYEVFARE | 26 | Q8IXF9 | |
| AAKGFELLYQPEVVR | 651 | O00192 | |
| YVIALVFNIFNLEPG | 1481 | Q7Z408 | |
| LRPKEFFRAYGIEVL | 251 | Q96NN9 | |
| PFLQAFYVDLQGVIK | 131 | O94788 | |
| TIRLPPGYQVKVFFL | 286 | Q5VXM1 | |
| AAFLNVYKRLIDVPD | 76 | P39880 | |
| YIAQFFKIPIAEIAV | 266 | Q9Y673 | |
| DIYEKQPVPFGLVRF | 66 | P22570 | |
| GFVIPSVLIILFYQK | 231 | Q15760 | |
| PYGLFGFQITKLIVE | 2231 | Q8WXG9 | |
| LYKNGLQRANFVPFI | 251 | Q8WV93 | |
| LNPVLYAFIGQKFRN | 311 | P51684 | |
| FLEKGFEREYRLAPI | 576 | P51828 | |
| KALLPVGAYEVFARE | 26 | A6NM10 | |
| FQPIDLIRKYFGEKI | 346 | Q9NQ90 | |
| IGFVLYAVPKEFQNI | 466 | Q9UMQ6 | |
| IFLFVPNLIGYARIV | 6 | O14735 | |
| PTGYRVKLVFQQFDL | 51 | P00736 | |
| QLVPGRLYEVKLVAF | 706 | Q8TDY8 | |
| ELVPVFERAGKIYEF | 76 | Q8TBY0 | |
| LIKAYGIRFDIIVFG | 311 | Q99571 | |
| IIALLKVPLSFQRYF | 781 | Q9NVH2 | |
| QPLFDKRFEIINAIY | 111 | P55209 | |
| PARVVYDLLFFFIVI | 2491 | Q14573 | |
| AYRVKPAVFDLLLAV | 516 | Q969V3 | |
| IQAKLIFLNFVRVPY | 96 | Q8N2K0 | |
| IFLNFVRVPYFIDLK | 101 | Q8N2K0 | |
| PQLFNKFALPYIRDV | 226 | P06132 | |
| LFPLREQGLNFYAKE | 161 | Q5TC84 | |
| FRPAIKYFGDIISVG | 126 | Q96CN7 | |
| IFVYNFIRPVKGKVS | 716 | Q6DN12 | |
| ELKFDRYSVFRPGVL | 156 | Q9BUP3 | |
| QRVLFLLDGYNEFKP | 241 | Q9NPP4 | |
| SIYVFVRDPAKLFLV | 106 | P10721 | |
| VLVKQFRPAVYAGEV | 56 | O95848 | |
| GLLDKFPLFTAVYQI | 316 | Q8N335 | |
| GIAFNFILDRKVPVY | 226 | Q7Z3F1 | |
| FILDRKVPVYVENFL | 231 | Q7Z3F1 | |
| VFFPVSEYKGILQLD | 286 | Q9NU53 | |
| IPGVLYEQFKFFLNL | 146 | O43861 | |
| LTFIYRFGKNVPEVV | 256 | Q9Y5P1 | |
| RVNKIYGLFVAFAIL | 196 | Q9H2C5 | |
| EIRYIFGAQVAPATK | 286 | Q9HC56 | |
| IALGIAFIGYFVEKP | 271 | Q96LB9 | |
| LLGFEKRFVPSQHYV | 11 | P14598 | |
| SVPLIVRYFRKVGFF | 171 | Q96KR6 | |
| VFGAAPLENVVRKYK | 146 | Q16656 | |
| RKAGFVIEAFTRLPY | 281 | Q9H1A3 | |
| DFLAFKERLYGPLQA | 391 | Q6ZTU2 | |
| KIDQYSRILFPVAFA | 416 | Q16445 | |
| EYEIAIRKVPGNFTF | 166 | Q13651 | |
| KVREADLVIFQFPLY | 91 | P16083 | |
| FYVPAEPKLAFVIRI | 81 | P18124 | |
| KQLAAFLEGFYEIIP | 4221 | Q7Z6Z7 | |
| GYKRERVPFVLTQDF | 946 | P42336 | |
| LLGFEKRFVPSQHYV | 11 | A6NI72 | |
| AAVPRFVQQKLYLFL | 406 | Q9NXE4 | |
| AELGARAKEFPNVYI | 181 | Q9H361 | |
| FALLNFVVKYSPERQ | 646 | O00469 | |
| LFNRTLPFYFVQKIE | 516 | Q9H0J9 | |
| YFGILKEARVTVFPF | 121 | Q9UBM1 | |
| TVFYLEPKRFGNQIT | 1091 | A2PYH4 | |
| KVIQPIFLGKIINYF | 106 | O15439 | |
| QELKPFPFGVRIDYV | 226 | O60906 | |
| FPFGVRIDYVLYKAV | 231 | O60906 | |
| NLLEKDYFGIRFVDP | 51 | Q7Z6J6 | |
| FVPAGYESALQVRKV | 356 | Q13535 | |
| PDKNYIRPEIFFALA | 81 | Q9NZH6 | |
| AGIIEKIALQFPYRF | 656 | Q8NB78 | |
| IFDEILLQVFPKFPY | 76 | A0A1B0GVN3 | |
| VNPVIYAFVGERFRK | 296 | P32246 | |
| LKPLFEQFGRIYELT | 61 | Q8N6W0 | |
| IIFKLSPQGYRFQKL | 236 | Q8N118 | |
| RVQPFYAALKEFVDL | 306 | O75936 | |
| FTLESVFVAPRKGIY | 106 | Q9NTU7 | |
| RSKGVFVQSVLPYFV | 221 | Q53GQ0 | |
| FGRLLNEALILKFPY | 126 | Q96DP5 | |
| NPIIYAFVGEKFRSL | 301 | P41597 | |
| TGFLLKENIRPFQLY | 486 | Q99062 | |
| GPFRFVDLYGAQKIV | 716 | P40939 | |
| GLLILAYPFLKARFN | 51 | A6PVL3 | |
| LYKQVLEPSFRQAFP | 171 | P26641 | |
| PLLFKYFLAEGIVNG | 96 | Q96EB1 | |
| APRYTGFLKGLLQVF | 421 | Q9Y2C5 | |
| KFEVFQPGDYIIREG | 561 | Q9UL51 | |
| GNYLFPRELFKLVVG | 141 | Q9BVI4 | |
| SPAILVLVNYIFFKG | 191 | P08185 | |
| LDPNLYRIGQSKIFF | 756 | P35580 | |
| PELQGQLFVAFLVIY | 21 | Q8NH74 | |
| AVRLYRKALEVFPEF | 346 | O15294 | |
| VGPIERKGFYLAFQD | 176 | Q9UF33 | |
| AAVYLREPQKTLFFV | 396 | O60882 | |
| KPRIFFLFNDILVYG | 51 | Q96S99 | |
| KLSLRNFIEFVFPYR | 806 | A6NKG5 | |
| TFAFKVPYVELGGRV | 176 | O00445 | |
| RLKDANKFGYPFVII | 421 | Q7L3T8 | |
| LTRKGIVRVVFFPFF | 111 | Q8N3S3 | |
| YEFAGKRVPFLVLAA | 236 | Q16572 | |
| VYNEESFVFRKVILP | 751 | Q15147 | |
| IYFQGFRVDLPIKSA | 256 | Q9H9S3 | |
| QRFILQVVLAGAFYP | 736 | Q8NDG6 | |
| GRTFGYFPKDLIQVV | 91 | Q5JRA6 | |
| FVLEKFNLPAGYVGL | 261 | Q6NT16 | |
| VFGSKFRIEYEPLVA | 101 | O60934 | |
| PFRAGNEYLIFQKII | 281 | O15530 | |
| IRYLPKGFLNQFTED | 126 | Q05397 | |
| PRPLNKYQGFIFDIV | 1511 | Q14524 | |
| TLAFDEYGRPFLIIK | 6 | P48643 | |
| KFTLRIIYDQVGRPF | 1866 | Q9NT68 | |
| NGAELLYKRIIRPFF | 131 | Q00765 | |
| LVGLDLFVFPYRVVA | 361 | A4QPH2 | |
| FAGVVLYLKFRLPEI | 306 | P07225 | |
| FYIGQIPLKEVTFAR | 86 | O15047 | |
| VVKDFPIARYQGLQF | 351 | Q76KP1 | |
| RGEVVKAFVVLNPDY | 516 | Q53FZ2 | |
| FFILRRKPVEGYDIS | 101 | P59998 | |
| LDPNLYRIGQSKIFF | 756 | P35749 | |
| ADFKDALARVYGVIP | 166 | O00584 | |
| FERAVQYNEPLKVFL | 1681 | Q14690 | |
| CFNPVLYVFVGVKFR | 281 | P46094 | |
| KAYLFKGNILLREFP | 101 | Q9P2K2 | |
| FPAYERVLLREAGFK | 716 | Q9UDY2 | |
| IYFQGFRVDLPIKSA | 256 | P61619 | |
| ESEKFYVGQPRFLLL | 1896 | Q9H5I5 | |
| GILQLYFLKRLFNVP | 216 | Q8WW62 | |
| FKSRYGLVFRAQPVE | 136 | Q8IY51 | |
| PFVYQTIVKDIRAFD | 826 | Q8IZH2 | |
| VRVPQYFKDLFRILG | 341 | P78562 | |
| VERILFIYAKLNPGI | 211 | Q9NVG8 | |
| LRKGVNYEIKARPFF | 741 | Q9Y6N7 | |
| QKYIERPLLIFGTKF | 321 | Q9Y4R7 | |
| NYIGSFLARAKFIPL | 291 | A6NIE6 | |
| LEPQDVVRFGVFLYT | 126 | Q9Y5Z9 | |
| QVAFPLQYTPRKFVI | 776 | Q15393 | |
| VATFLRVDPAKGLFY | 661 | O75643 | |
| NYRNLVFLGIAAFKP | 36 | O43345 | |
| VGVLIAAYIIRFKPE | 286 | O14863 | |
| EFFYPELVKNIRGKV | 61 | Q9NPG3 | |
| VIYIFFDIKLLRNIP | 156 | Q6XPS3 | |
| IRVFSVPDGQKLYEF | 211 | Q5MNZ9 | |
| PAFKYFIRRDFVQVV | 1666 | O15050 | |
| LNFIYRKELFFLPLG | 236 | Q9H9Y6 | |
| QKLPDIFSVYFRREG | 911 | Q14669 | |
| YKQVQVPRGRLFAFD | 661 | A4D1P6 | |
| RFLVLNYKDKFEPGI | 286 | Q8N8N7 | |
| SFLYEGPKVIFRFAL | 851 | Q9UPU7 | |
| PITKQYQGLERFFIF | 586 | A8MT70 | |
| FLDAAEYGNIPVVRK | 31 | Q13507 | |
| FKVLLEKGFNPRILY | 811 | Q5T7N2 | |
| QFAKFLQRYAILTPE | 626 | O00160 | |
| VLFFHQLVGDPLKRY | 101 | Q53FP2 | |
| DAIQEKFYPPRFIQV | 241 | Q9UBF9 | |
| VPRIFKDLGYPFALS | 151 | O14777 |